- Home
- ARMP vs BW Comparison
ARMP vs BW Comparison
Compare ARMP & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- BW
- Stock Information
- Founded
- ARMP N/A
- BW 1867
- Country
- ARMP United States
- BW United States
- Employees
- ARMP N/A
- BW N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- BW Building Products
- Sector
- ARMP Health Care
- BW Industrials
- Exchange
- ARMP Nasdaq
- BW Nasdaq
- Market Cap
- ARMP 52.1M
- BW 45.3M
- IPO Year
- ARMP N/A
- BW N/A
- Fundamental
- Price
- ARMP $1.95
- BW $0.70
- Analyst Decision
- ARMP Strong Buy
- BW Buy
- Analyst Count
- ARMP 1
- BW 2
- Target Price
- ARMP $9.00
- BW $3.50
- AVG Volume (30 Days)
- ARMP 624.1K
- BW 1.8M
- Earning Date
- ARMP 05-14-2025
- BW 05-12-2025
- Dividend Yield
- ARMP N/A
- BW N/A
- EPS Growth
- ARMP N/A
- BW N/A
- EPS
- ARMP N/A
- BW N/A
- Revenue
- ARMP $4,699,000.00
- BW $734,239,000.00
- Revenue This Year
- ARMP $8.43
- BW $9.70
- Revenue Next Year
- ARMP N/A
- BW $10.16
- P/E Ratio
- ARMP N/A
- BW N/A
- Revenue Growth
- ARMP 14.24
- BW 12.90
- 52 Week Low
- ARMP $0.90
- BW $0.22
- 52 Week High
- ARMP $3.42
- BW $2.99
- Technical
- Relative Strength Index (RSI)
- ARMP 56.79
- BW 52.92
- Support Level
- ARMP $1.74
- BW $0.63
- Resistance Level
- ARMP $2.20
- BW $0.79
- Average True Range (ATR)
- ARMP 0.32
- BW 0.12
- MACD
- ARMP 0.04
- BW -0.00
- Stochastic Oscillator
- ARMP 50.32
- BW 41.73
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.